<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="mckd2" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">mckd2</book-part-id>
      <title-group>
        <title>Autosomal Dominant Tubulointerstitial Kidney Disease<italic toggle="yes">, UMOD</italic>-Related</title>
        <alt-title alt-title-type="alt-title">Synonyms: ADTKD-<italic toggle="yes">UMOD</italic>, Familial Juvenile Hyperuricemic Nephropathy 1, Medullary Cystic Kidney Disease 2, <italic toggle="yes">UMOD</italic>-Associated Kidney Disease, Uromodulin Kidney Disease</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Bleyer</surname>
            <given-names>Anthony J</given-names>
          </name>
          <degrees>MD, MS</degrees>
          <aff>Section on Nephrology<break/>Wake Forest University School of Medicine<break/>Winston-Salem, North Carolina</aff>
          <email>ableyer@wfubmc.edu</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Hart</surname>
            <given-names>P Suzanne</given-names>
          </name>
          <degrees>PhD</degrees>
          <aff>Office of the Clinical Director<break/>National Human Genome Research Institute<break/>National Institutes of Health<break/>Bethesda, Maryland</aff>
          <email>shart@mail.nih.gov</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Kmoch</surname>
            <given-names>Stanislav</given-names>
          </name>
          <degrees>PhD</degrees>
          <aff>Institute for Inherited Metabolic Disorders<break/>First Faculty of Medicine<break/>Charles University<break/>Prague, Czech Republic</aff>
          <email>skmoch@lf1.cuni.cz</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date date-type="created">
          <day>12</day>
          <month>1</month>
          <year>2007</year>
        </date>
        <date date-type="updated">
          <day>30</day>
          <month>6</month>
          <year>2016</year>
        </date>
        <date date-type="revised">
          <day>26</day>
          <month>9</month>
          <year>2007</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="hyper-nfj2" document-type="chapter">Autosomal Dominant Tubulointerstitial Kidney Disease, <italic toggle="yes">REN</italic>-Related</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="li-ar" document-type="chapter">Autosomal Recessive Congenital Ichthyosis</related-object>
      <abstract id="mckd2.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>Autosomal dominant tubulointerstitial kidney disease caused by <italic toggle="yes">UMOD</italic> pathogenic variants (ADTKD-<italic toggle="yes">UMOD</italic>) was previously known as familial juvenile hyperuricemic nephropathy type 1 (FJHN1), medullary cystic kidney disease type 2 (MCKD2), and <italic toggle="yes">UMOD</italic>-associated kidney disease (or uromodulin-associated kidney disease). Typical clinical findings:</p>
          <list list-type="bullet">
            <list-item>
              <p>Urinalysis revealing minimal protein and no blood</p>
            </list-item>
            <list-item>
              <p>Slowly progressive chronic kidney failure, usually first noted in the teen years and progressing to end-stage renal disease (ESRD) between the fourth and seventh decades (Age at ESRD varies among and within families.)</p>
            </list-item>
            <list-item>
              <p>Hyperuricemia and gout (resulting from reduced kidney excretion of uric acid) that occurs as early as the teenage years</p>
            </list-item>
          </list>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>ADTKD-<italic toggle="yes">UMOD</italic> is defined by the presence of a heterozygous pathogenic variant in <italic toggle="yes">UMOD</italic>, the gene encoding uromodulin. The majority of persons with ADTKD-<italic toggle="yes">UMOD</italic> have the following laboratory test abnormalities: elevated serum creatinine (decreased estimated glomerular filtration rate), bland urinary sediment, elevated serum urate level, and reduced fractional excretion of uric acid. In children with the disorder, serum creatinine levels may be normal but elevated serum urate levels are usually present.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations</italic>: Allopurinol or probenecid for prevention of gout; referral to a nephrologist to monitor kidney function, evaluate for manifestations of chronic kidney disease, and prepare for renal replacement therapy. Hemodialysis and peritoneal dialysis can replace renal function; kidney transplantation is curative.</p>
          <p><italic toggle="yes">Prevention of primary manifestations</italic>: Allopurinol, febuxostat, or probenecid lowers high serum urate levels effectively and will prevent development of gout.</p>
          <p><italic toggle="yes">Surveillance</italic>: Measurement of serum concentration of creatinine and uric acid at least annually.</p>
          <p><italic toggle="yes">Agents/circumstances to avoid</italic>: Drugs known to be nephrotoxic; volume depletion and dehydration; high meat and seafood intake (may exacerbate hyperuricemia/gout).</p>
          <p><italic toggle="yes">Evaluation of relatives at risk</italic>: If the causative <italic toggle="yes">UMOD</italic> pathogenic variant has been identified in an affected family member, offer molecular genetic testing to at-risk relatives, particularly: (1) adolescents because of the benefit of allopurinol administration for the prevention of gout; (2) potential kidney donors.</p>
          <p><italic toggle="yes">Pregnancy management</italic>: Allopurinol should be discontinued in women who are pregnant or who may become pregnant. Women taking an angiotensin-converting enzyme inhibitor and who are pregnant or may become pregnant should transition to another antihypertensive medication. Ideally women should not be taking either allopurinol or an ACE inhibitor during pregnancy.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>ADTKD-<italic toggle="yes">UMOD</italic> is inherited in an autosomal dominant manner. Most individuals diagnosed with ADTKD-<italic toggle="yes">UMOD</italic> have an affected parent. Each child of an affected individual has a 50% chance of inheriting the pathogenic variant. Prenatal testing is possible for pregnancies at increased risk in families in which the pathogenic variant has been identified.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="mckd2.Diagnosis">
        <title>Diagnosis</title>
        <sec id="mckd2.Suggestive_Findings">
          <title>Suggestive Findings</title>
          <p>Autosomal dominant tubulointerstitial kidney disease, <italic toggle="yes">UMOD</italic>-related (ADTKD-<italic toggle="yes">UMOD</italic>) <bold>should be suspected</bold> in individuals with the following findings:</p>
          <p>
            <bold>Clinical</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Tubulointerstitial kidney disease.</bold> Urinalysis of affected individuals reveals few or no red cells or white cells, and &#x0003c;500 mg of urinary protein.</p>
            </list-item>
            <list-item>
              <p><bold>Slowly progressive chronic kidney disease.</bold> Affected individuals usually develop asymptomatic elevations in their serum creatinine concentration between ages ten and 40 years, although asymptomatic elevations may occur at a younger age [<xref ref-type="bibr" rid="mckd2.REF.sch_ffer.2010.1355">Sch&#x000e4;ffer et al 2010</xref>]. End-stage renal disease (ESRD) usually develops in the fourth to seventh decade of life [<xref ref-type="bibr" rid="mckd2.REF.bleyer.2003.36">Bleyer et al 2003</xref>].</p>
            </list-item>
            <list-item>
              <p><bold>Hyperuricemia and gout,</bold> found in most (not all) affected individuals. Elevated serum uric acid concentrations are usually present in childhood and often result in gout in the teen years, especially in young men, though it also can occur in women [<xref ref-type="bibr" rid="mckd2.REF.bleyer.2003.36">Bleyer et al 2003</xref>]. Some families have milder forms of disease, and in these families, gout may be uncommon or absent in family members [<xref ref-type="bibr" rid="mckd2.REF.smith.2011.2766">Smith et al 2011</xref>].</p>
            </list-item>
            <list-item>
              <p><bold>Autosomal dominant inheritance.</bold> The presence of chronic kidney disease (elevated serum creatinine) or ESRD inherited in an autosomal dominant manner is another important clue to this disorder.</p>
            </list-item>
          </list>
          <sec id="mckd2.Testing">
            <title>Testing</title>
            <p>The majority of persons with ADTKD-<italic toggle="yes">UMOD</italic> have the following laboratory test abnormalities: elevated serum creatinine (decreased estimated glomerular filtration rate), bland urinary sediment, elevated serum urate level, and reduced fractional excretion of uric acid. In children with the disorder, serum creatinine levels may be normal but elevated serum urate levels are usually present.</p>
            <p><bold>Serum creatinine (eGFR</bold>)<bold>.</bold> As individuals with ADTKD-<italic toggle="yes">UMOD</italic> age, kidney function worsens, and the serum creatinine rises.</p>
            <list list-type="bullet">
              <list-item>
                <p>The serum creatinine is an indirect measure of glomerular filtration rate, and there are formulas that calculate the estimated glomerular filtration rate from the serum creatinine.</p>
                <p>Note: On most laboratory reports, the estimated glomerular filtration rate is included. However, calculators for this purpose are available online (see, e.g., <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.mdcalc.com/mdrd-gfr-equation/">www.mdcalc.com</ext-link>).</p>
              </list-item>
              <list-item>
                <p>A reduced eGFR (&#x0003c;90 mL/min/1.73 m<sup>2</sup>) is a sensitive indicator of ADTKD-<italic toggle="yes">UMOD</italic> in adults, but it is not specific, as many individuals in the general population have mildly decreased eGFR measurements.</p>
              </list-item>
              <list-item>
                <p>The lower the eGFR in an affected family member, the more likely it is to indicate ADTKD-UMOD: very few individuals in the general population have an eGFR &#x0003c;60 mL/min/1.73 m<sup>2</sup>.</p>
              </list-item>
            </list>
            <p><bold>Urinalysis.</bold> In almost all individuals with ADTKD-<italic toggle="yes">UMOD</italic>, the urinary sediment is bland, with &#x0003c;3 red blood cells/high power field and urinary protein on dipstick negative or 1+.</p>
            <list list-type="bullet">
              <list-item>
                <p>A 24-hour urinary collection yields &#x0003c;500 grams protein/24 hours.</p>
              </list-item>
              <list-item>
                <p>A spot urinary protein:creatinine ratio will be &#x0003c;500 mg protein/g creatinine.</p>
              </list-item>
              <list-item>
                <p>Rarely, in advanced kidney disease, the urinary protein may be increased.</p>
              </list-item>
            </list>
            <p><bold>Serum concentration of uric acid.</bold> Hyperuricemia (serum uric acid concentration &#x0003e;6 mg/dL) is present in the vast majority of individuals with ADTKD-<italic toggle="yes">UMOD</italic>, even prior to the development of kidney failure.</p>
            <list list-type="bullet">
              <list-item>
                <p>In children, hyperuricemia is more likely to be present than an elevated serum creatinine concentration.</p>
              </list-item>
              <list-item>
                <p>Usually, hyperuricemia in an individual with normal kidney function corresponds to a serum concentration of uric acid &#x0003e;1 SD above the normal value for age and sex.</p>
              </list-item>
            </list>
            <p>Note: It is important to compare the serum uric acid concentration with age- and gender-specific normal values (see <xref ref-type="table" rid="mckd2.T.serum_uric_acid_concentration_in">Table 1</xref>) [<xref ref-type="bibr" rid="mckd2.REF.wilcox.1996.731">Wilcox 1996</xref>].</p>
            <table-wrap id="mckd2.T.serum_uric_acid_concentration_in" orientation="portrait" position="anchor">
              <label>Table 1. </label>
              <caption>
                <p>Serum Uric Acid Concentration in Individuals with Normal Renal Function</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_mckd2.T.serum_uric_acid_concentration_in_1_1_1_1" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_mckd2.T.serum_uric_acid_concentration_in_1_1_1_1">Age</th>
                    <th id="hd_h_mckd2.T.serum_uric_acid_concentration_in_1_1_1_2" valign="middle" colspan="2" align="left" scope="colgroup" rowspan="1">Serum Concentration (mg/dL)</th>
                  </tr>
                  <tr>
                    <th headers="hd_h_mckd2.T.serum_uric_acid_concentration_in_1_1_1_2" id="hd_h_mckd2.T.serum_uric_acid_concentration_in_1_1_2_1" valign="middle" colspan="1" align="left" scope="colgroup" rowspan="1">Males</th>
                    <th headers="hd_h_mckd2.T.serum_uric_acid_concentration_in_1_1_1_2" id="hd_h_mckd2.T.serum_uric_acid_concentration_in_1_1_2_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Females</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_mckd2.T.serum_uric_acid_concentration_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">&#x0003c;5 years</td>
                    <td headers="hd_h_mckd2.T.serum_uric_acid_concentration_in_1_1_1_2 hd_h_mckd2.T.serum_uric_acid_concentration_in_1_1_2_1 hd_h_mckd2.T.serum_uric_acid_concentration_in_1_1_2_2" valign="middle" colspan="2" align="center" rowspan="1">3.6&#x000b1;0.9</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_mckd2.T.serum_uric_acid_concentration_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">5-10 years</td>
                    <td headers="hd_h_mckd2.T.serum_uric_acid_concentration_in_1_1_1_2 hd_h_mckd2.T.serum_uric_acid_concentration_in_1_1_2_1 hd_h_mckd2.T.serum_uric_acid_concentration_in_1_1_2_2" valign="middle" colspan="2" align="center" rowspan="1">4.1&#x000b1;1.0</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_mckd2.T.serum_uric_acid_concentration_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">12 years</td>
                    <td headers="hd_h_mckd2.T.serum_uric_acid_concentration_in_1_1_1_2 hd_h_mckd2.T.serum_uric_acid_concentration_in_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">4.4&#x000b1;1.1</td>
                    <td headers="hd_h_mckd2.T.serum_uric_acid_concentration_in_1_1_1_2 hd_h_mckd2.T.serum_uric_acid_concentration_in_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">4.5&#x000b1;0.9</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_mckd2.T.serum_uric_acid_concentration_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">15 years</td>
                    <td headers="hd_h_mckd2.T.serum_uric_acid_concentration_in_1_1_1_2 hd_h_mckd2.T.serum_uric_acid_concentration_in_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">5.6&#x000b1;1.1</td>
                    <td headers="hd_h_mckd2.T.serum_uric_acid_concentration_in_1_1_1_2 hd_h_mckd2.T.serum_uric_acid_concentration_in_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">4.5&#x000b1;0.9</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_mckd2.T.serum_uric_acid_concentration_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">&#x0003e;18 years</td>
                    <td headers="hd_h_mckd2.T.serum_uric_acid_concentration_in_1_1_1_2 hd_h_mckd2.T.serum_uric_acid_concentration_in_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">6.2&#x000b1;0.8</td>
                    <td headers="hd_h_mckd2.T.serum_uric_acid_concentration_in_1_1_1_2 hd_h_mckd2.T.serum_uric_acid_concentration_in_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">4.0&#x000b1;0.7</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn>
                  <p><xref ref-type="bibr" rid="mckd2.REF.mikkelsen.1965.242">Mikkelsen et al [1965]</xref>, <xref ref-type="bibr" rid="mckd2.REF.harkness.1969.773">Harkness &#x00026; Nicol [1969]</xref>, <xref ref-type="bibr" rid="mckd2.REF.wilcox.1996.731">Wilcox [1996]</xref></p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <p><bold>Fractional excretion of urinary uric acid</bold> is usually decreased in ADTKD-<italic toggle="yes">UMOD</italic> [<xref ref-type="bibr" rid="mckd2.REF.moro.1991.263">Moro et al 1991</xref>].</p>
            <p>The fractional excretion of urinary uric acid can be calculated as shown:</p>
            <table-wrap id="mckd2.Tc" orientation="portrait" position="anchor">
              <table frame="hsides" rules="groups">
                <tbody>
                  <tr>
                    <td valign="top" align="left" rowspan="1" colspan="1">Urinary uric acid c. <bold>x</bold> serum creatinine c. <bold>&#x000f7;</bold> serum uric acid c. <bold>x</bold> urine creatinine c.</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn>
                  <p>c. = concentration</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <p>In ADTKD-<italic toggle="yes">UMOD</italic>, the fractional excretion of uric acid is usually &#x0003c;5% in adult men and &#x0003c;6% in adult women. The reduction of urate excretion is an early event since it can be detected in affected children with preserved renal function [<xref ref-type="bibr" rid="mckd2.REF.moro.1991.263">Moro et al 1991</xref>, <xref ref-type="bibr" rid="mckd2.REF.mcbride.1998.357">McBride et al 1998</xref>].</p>
            <p>Note: (1) The fractional excretion of urinary uric acid can be measured from a spot urine sample; however, a 24-hour urine collection is preferable. (2) Aspirin, diuretics, and nonsteroidal agents should be avoided during the collection. (3) Because the fractional excretion of uric acid rises above 5% as renal function worsens, this test is not sensitive in individuals with ADTKD-<italic toggle="yes">UMOD</italic> who have an estimated glomerular filtration rate &#x0003c;70 mL/min.</p>
            <p><xref ref-type="table" rid="mckd2.T.fractional_excretion_of_urinary">Table 2</xref> provides the reference ranges by age in individuals with normal kidney function. A fractional excretion of urate &#x0003e;1 SD below the mean suggests reduced urate excretion.</p>
            <table-wrap id="mckd2.T.fractional_excretion_of_urinary" orientation="portrait" position="anchor">
              <label>Table 2. </label>
              <caption>
                <p>Fractional Excretion of Urinary Uric Acid in Individuals with Normal Renal Function</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_mckd2.T.fractional_excretion_of_urinary_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Age (Gender)</th>
                    <th id="hd_h_mckd2.T.fractional_excretion_of_urinary_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Mean (%)</th>
                    <th id="hd_h_mckd2.T.fractional_excretion_of_urinary_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Standard Deviation</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_mckd2.T.fractional_excretion_of_urinary_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">0-6 weeks</td>
                    <td headers="hd_h_mckd2.T.fractional_excretion_of_urinary_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">29.1</td>
                    <td headers="hd_h_mckd2.T.fractional_excretion_of_urinary_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">11.7</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_mckd2.T.fractional_excretion_of_urinary_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">6 weeks - 1 year</td>
                    <td headers="hd_h_mckd2.T.fractional_excretion_of_urinary_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">23.9</td>
                    <td headers="hd_h_mckd2.T.fractional_excretion_of_urinary_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">10.4</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_mckd2.T.fractional_excretion_of_urinary_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">1-3 years</td>
                    <td headers="hd_h_mckd2.T.fractional_excretion_of_urinary_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">15.2</td>
                    <td headers="hd_h_mckd2.T.fractional_excretion_of_urinary_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">6.2</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_mckd2.T.fractional_excretion_of_urinary_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">3-13 years</td>
                    <td headers="hd_h_mckd2.T.fractional_excretion_of_urinary_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">12.2</td>
                    <td headers="hd_h_mckd2.T.fractional_excretion_of_urinary_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">5.5</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_mckd2.T.fractional_excretion_of_urinary_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">&#x0003e;13 years (male)</td>
                    <td headers="hd_h_mckd2.T.fractional_excretion_of_urinary_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">8.0</td>
                    <td headers="hd_h_mckd2.T.fractional_excretion_of_urinary_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">3.7</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_mckd2.T.fractional_excretion_of_urinary_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">&#x0003e;13 years (female)</td>
                    <td headers="hd_h_mckd2.T.fractional_excretion_of_urinary_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">10.3</td>
                    <td headers="hd_h_mckd2.T.fractional_excretion_of_urinary_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">4.2</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn>
                  <p>
                    <xref ref-type="bibr" rid="mckd2.REF.stib_rkov_.2006.1301">Stib&#x0016f;rkov&#x000e1; et al [2006]</xref>
                  </p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <p>
              <bold>Kidney imaging and histology</bold>
            </p>
            <list list-type="bullet">
              <list-item>
                <p><bold>Renal ultrasound examination</bold> usually reveals normal kidneys. With more advanced disease, small kidneys may be seen. The ultrasound is not helpful in making the diagnosis of ADTKD-<italic toggle="yes">UMOD</italic>, except for ruling out polycystic kidney disease or other conditions as a cause of kidney failure.</p>
              </list-item>
              <list-item>
                <p><bold>Kidney biopsy.</bold> Histologic examination shows chronic interstitial fibrosis, with focal tubular atrophy and interstitial fibrosis, occasionally accompanied by lymphocytic infiltration. The main lesions include tubular basement membrane disintegration (thickening and attenuation) and medullary cyst formation in distal tubules and collecting ducts [<xref ref-type="bibr" rid="mckd2.REF.simmonds.1980.176">Simmonds et al 1980</xref>, <xref ref-type="bibr" rid="mckd2.REF.richmond.1981.163">Richmond et al 1981</xref>, <xref ref-type="bibr" rid="mckd2.REF.gagnadoux.1989.50">Gagnadoux et al 1989</xref>, <xref ref-type="bibr" rid="mckd2.REF.puig.1993.357">Puig et al 1993</xref>, <xref ref-type="bibr" rid="mckd2.REF.dahan.2001.2348">Dahan et al 2001</xref>].</p>
                <p>Note: (1) Biopsy interpretation may be misleading: many pathologists focus on glomerular changes (which are secondary) and may make the incorrect diagnosis of focal glomerulosclerosis [<xref ref-type="bibr" rid="mckd2.REF.bleyer.2005.824">Bleyer et al 2005</xref>]. (2) Kidney biopsy should <bold>not</bold> be performed to establish a diagnosis of ADTKD-<italic toggle="yes">UMOD</italic> because it is an invasive procedure with some risk; and pathologic findings are too nonspecific to reliably identify the causative disorder.</p>
              </list-item>
            </list>
          </sec>
        </sec>
        <sec id="mckd2.Establishing_the_Diagnosis">
          <title>Establishing the Diagnosis</title>
          <p>The diagnosis of ADTKD-<italic toggle="yes">UMOD</italic>
<bold>is established</bold> in a proband by identification of a heterozygous pathogenic variant in <italic toggle="yes">UMOD</italic> by molecular genetic testing (see <xref ref-type="table" rid="mckd2.T.summary_of_molecular_genetic_tes">Table 3</xref>).</p>
          <p>Molecular testing approaches can include <bold>single-gene testing</bold>, use of a <bold>multi-gene panel</bold>, and <bold>more comprehensive</bold>
<bold>genomic testing</bold>:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Single-gene testing.</bold> Full sequence analysis of <italic toggle="yes">UMOD</italic> has identified all causative pathogenic variants in ADTKD-<italic toggle="yes">UMOD</italic>. Since ADTKD-<italic toggle="yes">UMOD</italic> occurs through a gain-of-function mechanism and large intragenic deletion or duplication has not been reported, testing for intragenic deletions or duplication is unlikely to identify a disease-causing variant.</p>
            </list-item>
            <list-item>
              <p><bold>A multi-gene panel</bold> that includes <italic toggle="yes">UMOD</italic> and other genes of interest (see <xref ref-type="sec" rid="mckd2.Differential_Diagnosis">Differential Diagnosis</xref>) may also be considered. Note: The genes included in the panel and the diagnostic sensitivity of the testing used for each gene vary by laboratory and over time.</p>
            </list-item>
            <list-item>
              <p><bold>More comprehensive genomic testing</bold> (when available) including exome sequencing and genome sequencing may be considered if serial single-gene testing (and/or use of a multi-gene panel that includes <italic toggle="yes">UMOD</italic>) fails to confirm a diagnosis in an individual with features of ADTKD-<italic toggle="yes">UMOD</italic>. Such testing may provide or suggest a diagnosis not previously considered (e.g., mutation of a different gene that results in a similar clinical presentation). For more information on comprehensive genome sequencing click <related-object link-type="booklink" source-id="gene" document-id="app5" document-type="appendix" object-id="app5.Comprehensive_Genome_Sequencing" object-type="sec">here</related-object>.</p>
            </list-item>
          </list>
          <table-wrap id="mckd2.T.summary_of_molecular_genetic_tes" orientation="portrait" position="anchor">
            <label>Table 3. </label>
            <caption>
              <p>Summary of Molecular Genetic Testing Used in ADTKD-<italic toggle="yes">UMOD</italic></p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_mckd2.T.summary_of_molecular_genetic_tes_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                  <th id="hd_h_mckd2.T.summary_of_molecular_genetic_tes_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Test Method</th>
                  <th id="hd_h_mckd2.T.summary_of_molecular_genetic_tes_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Proportion of Probands with a Pathogenic<break/>Variant&#x000a0;<sup>2</sup> Detectable by This Method</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_mckd2.T.summary_of_molecular_genetic_tes_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                    <italic toggle="yes">UMOD</italic>
                  </td>
                  <td headers="hd_h_mckd2.T.summary_of_molecular_genetic_tes_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>3</sup></td>
                  <td headers="hd_h_mckd2.T.summary_of_molecular_genetic_tes_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">&#x0003e;95%&#x000a0;<sup>4</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_mckd2.T.summary_of_molecular_genetic_tes_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Gene-targeted deletion/duplication analysis&#x000a0;<sup>5</sup></td>
                  <td headers="hd_h_mckd2.T.summary_of_molecular_genetic_tes_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Unknown; none reported&#x000a0;<sup>6</sup></td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="mckd2.TF.3.1">
                <label>1. </label>
                <p>See <related-object source-id="gene" document-id="mckd2" object-id="mckd2.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
              </fn>
              <fn id="mckd2.TF.3.2">
                <label>2. </label>
                <p>See <xref ref-type="sec" rid="mckd2.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants detected in this gene.</p>
              </fn>
              <fn id="mckd2.TF.3.3">
                <label>3. </label>
                <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splic- site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
              </fn>
              <fn id="mckd2.TF.3.4">
                <label>4. </label>
                <p>Pathogenic variants in <italic toggle="yes">UMOD</italic> have been identified in exons 3, 4, 5, and 7 [<xref ref-type="bibr" rid="mckd2.REF.williams.2009.2963">Williams et al 2009</xref>]. Most variants are identified in exons 3 and 4. It is important to determine whether a diagnostic laboratory sequences all <italic toggle="yes">UMOD</italic> coding exons or only select exons, which may miss pathogenic variants in other exons. See <xref ref-type="sec" rid="mckd2.Molecular_Genetic_Pathogenesis">Molecular Genetic Pathogenesis</xref> regarding exon numbering of <italic toggle="yes">UMOD</italic>.</p>
              </fn>
              <fn id="mckd2.TF.3.5">
                <label>5. </label>
                <p>Gene-targeted deletion/duplication analysis detects intragenic deletions or duplications. Methods that may be used include: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a gene-targeted microarray designed to detect single-exon deletions or duplications.</p>
              </fn>
              <fn id="mckd2.TF.3.6">
                <label>6. </label>
                <p>No exon or whole-gene deletions or duplications have been reported as a cause of ADTKD-<italic toggle="yes">UMOD</italic>. This type of pathogenic variant would be an unlikely cause of this condition; thus, the clinical utility of such testing is unknown.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
      </sec>
      <sec id="mckd2.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="mckd2.Clinical_Description">
          <title>Clinical Description</title>
          <p>The initial presenting feature is either chronic tubulointerstial kidney disease (elevated serum creatinine) or gout.</p>
          <p><bold>Slowly progressive chronic tubulointerstitial kidney disease.</bold> Most commonly, the presenting sign is an elevated serum creatinine in a patient with a family history of kidney disease. A mild elevation in serum creatinine may occur in childhood and is usually incidentally noted on laboratory testing for other reasons or when screening is performed in children of an affected individual.</p>
          <list list-type="bullet">
            <list-item>
              <p>The chronic tubulointerstitial kidney disease of ADTKD-<italic toggle="yes">UMOD</italic> usually leads to end-stage renal disease (ESRD) between the fourth and seventh decades of life, although renal disease can progress to ESRD before age 30 years [<xref ref-type="bibr" rid="mckd2.REF.simmonds.1980.176">Simmonds et al 1980</xref>, <xref ref-type="bibr" rid="mckd2.REF.richmond.1981.163">Richmond et al 1981</xref>, <xref ref-type="bibr" rid="mckd2.REF.cameron.1993.105">Cameron et al 1993</xref>, <xref ref-type="bibr" rid="mckd2.REF.puig.1993.357">Puig et al 1993</xref>]. The age at ESRD varies both between and within families.</p>
            </list-item>
            <list-item>
              <p>Symptoms of ESRD include loss of appetite, nausea, cold intolerance, and fatigue. The age at ESRD varies both among and within families. For example, three affected individuals in one family had ESRD between age 46 and 50 years, whereas two others did not need renal replacement therapy at ages 56 and 63 years [<xref ref-type="bibr" rid="mckd2.REF.puig.1993.357">Puig et al 1993</xref>].</p>
            </list-item>
            <list-item>
              <p>Unlike most other kidney diseases, hypertension frequently does not occur in ADTKD-<italic toggle="yes">UMOD</italic>.</p>
            </list-item>
          </list>
          <p><bold>Gout.</bold> A history of gout is recorded in only 45% of individuals with a <italic toggle="yes">UMOD</italic> pathogenic variant, with onset ranging from ages eight to 38 years [<xref ref-type="bibr" rid="mckd2.REF.dahan.2003.2883">Dahan et al 2003</xref>].</p>
          <list list-type="bullet">
            <list-item>
              <p>Gout characteristically involves the big toe, other areas of the feet, the ankle, or the knees.</p>
            </list-item>
            <list-item>
              <p>Onset is acute with severe tenderness and redness of the affected joint.</p>
            </list-item>
            <list-item>
              <p>While not all affected individuals have gout, virtually all families have a number of family members who have gout.</p>
            </list-item>
            <list-item>
              <p>In those with a strong family history of ADTKD-<italic toggle="yes">UMOD</italic>, diagnosis of gout is usually made by the affected individual or a parent. As renal function worsens, gout worsens and the frequency of attacks increases.</p>
            </list-item>
            <list-item>
              <p>Without treatment, tophi (large subcutaneous depositions of uric acid) and crippling arthritis can develop.</p>
            </list-item>
            <list-item>
              <p>Hyperuricemia is not a constant finding: some women older than age 16 years who have a <italic toggle="yes">UMOD</italic> pathogenic variant have been found to have a normal serum uric acid concentration [<xref ref-type="bibr" rid="mckd2.REF.bleyer.2003.867">Bleyer &#x00026; Hart 2003</xref>, <xref ref-type="bibr" rid="mckd2.REF.dahan.2003.2883">Dahan et al 2003</xref>].</p>
            </list-item>
          </list>
        </sec>
        <sec id="mckd2.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>The pathogenic variant <xref ref-type="table" rid="mckd2.T.umod_pathogenic_variants_discuss">p.Val93_Gly97del/insAASC</xref> is associated with less frequent gout and possibly a later age of onset of ESRD [<xref ref-type="bibr" rid="mckd2.REF.smith.2011.2766">Smith et al 2011</xref>].</p>
        </sec>
        <sec id="mckd2.Penetrance">
          <title>Penetrance</title>
          <p>Penetrance appears to be complete, although some individuals (especially females) may not develop ESRD until the sixth or seventh decade.</p>
          <p>The penetrance of hyperuricemia has been estimated at 92% in people with ADTKD-<italic toggle="yes">UMOD</italic> [<xref ref-type="bibr" rid="mckd2.REF.bleyer.2003.36">Bleyer et al 2003</xref>].</p>
        </sec>
        <sec id="mckd2.Nomenclature">
          <title>Nomenclature</title>
          <p>According to the nomenclature from 2015 [<xref ref-type="bibr" rid="mckd2.REF.eckardt.2015.676">Eckardt et al 2015</xref>] the term "autosomal dominant tubulointerstitial kidney disease" (ADTKD) refers to the following disorders characterized by: (1) autosomal dominant inheritance; (2) slowly progressive chronic tubulointerstitial kidney disease resulting in ESRD in the third through seventh decade of life; (3) urinalysis revealing a bland urinary sediment (i.e., little blood or protein); and (4) renal ultrasound examination that is normal early in the disease course [<xref ref-type="bibr" rid="mckd2.REF.bleyer.2010.366">Bleyer et al 2010</xref>]:</p>
          <list list-type="bullet">
            <list-item>
              <p><related-object link-type="booklink" source-id="gene" document-id="mckd1" document-type="chapter"><bold>Autosomal dominant tubulointerstitial kidney disease &#x02013; <italic toggle="yes">MUC1</italic>-related</bold><bold> (ADTKD<italic toggle="yes">-MUC1</italic>) </bold>(previously medullary cystic kidney disease type 1</related-object>). Autosomal dominant interstitial kidney disease that is associated with a pathogenic variant in <italic toggle="yes">MUC1</italic> [<xref ref-type="bibr" rid="mckd2.REF.kirby.2013.299">Kirby et al 2013</xref>]</p>
            </list-item>
            <list-item>
              <p><bold>Autosomal dominant tubulointerstitial kidney disease &#x02013; <italic toggle="yes">UMOD</italic>-related (ADTKD-<italic toggle="yes">UMOD</italic>)</bold> (previously <italic toggle="yes">UMOD</italic>-associated kidney disease). Familial juvenile hyperuricemic nephropathy type 1, medullary cystic kidney disease type 2 [MCKD2], and uromodulin storage disease</p>
            </list-item>
            <list-item>
              <p><related-object link-type="booklink" source-id="gene" document-id="hyper-nfj2" document-type="chapter"><bold>Autosomal dominant tubulointerstitial kidney disease &#x02013; <italic toggle="yes">REN</italic>-related</bold>
<bold>(ADTKD-<italic toggle="yes">REN</italic>) </bold>(previously familial juvenile hyperuricemic nephropathy type 2</related-object>). Also known as <italic toggle="yes">REN</italic>-associated kidney disease [<xref ref-type="bibr" rid="mckd2.REF.zivn_.2009.204">Zivn&#x000e1; et al 2009</xref>]</p>
            </list-item>
          </list>
          <p>Note: (1) The term "nephronophthisis/medullary cystic kidney disease (NPH/MCKD) complex" was used in the past to refer to both autosomal recessive and autosomal dominant forms of hereditary chronic tubulointerstitial disease [<xref ref-type="bibr" rid="mckd2.REF.hildebrandt.1992.802">Hildebrandt et al 1992</xref>]. Nephronophthisis is now used to refer to a group of conditions with autosomal recessive inheritance that present in childhood with chronic kidney failure. These conditions are caused by pathogenic variants in at least 12 different genes, denoted as nephrocystins (<italic toggle="yes">NPHP1</italic> &#x02013; <italic toggle="yes">NPHP11</italic>; <italic toggle="yes">NPHP1L</italic>) [<xref ref-type="bibr" rid="mckd2.REF.wolf.2011.181">Wolf &#x00026; Hildebrandt 2011</xref>]. Clinical characteristics include polyuria, anemia, and slowly progressive kidney failure. See <related-object link-type="booklink" source-id="gene" document-id="nephron-ov" document-type="chapter">Nephronophthisis</related-object>. (2) Medullary sponge kidney (MSK), associated with calcifications of the medulla of the kidney, hypercalciuria, hematuria, and tubular acidification defects [<xref ref-type="bibr" rid="mckd2.REF.gambaro.2006.663">Gambaro et al 2006</xref>], is not in any way related to medullary cystic kidney disease.</p>
        </sec>
        <sec id="mckd2.Prevalence">
          <title>Prevalence</title>
          <p>ADTKD-<italic toggle="yes">UMOD</italic> is rare, accounting for &#x0003c;1% of ESRD. However, ADTKD-<italic toggle="yes">UMOD</italic> has been chronically underdiagnosed and prevalence rates may be somewhat higher.</p>
        </sec>
      </sec>
      <sec id="mckd2.Genetically_Related_Allelic_Disord">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>No phenotypes other than those discussed in this <italic toggle="yes">GeneReview</italic> are known to be associated with germline pathogenic variants in <italic toggle="yes">UMOD</italic>.</p>
      </sec>
      <sec id="mckd2.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>See <xref ref-type="fig" rid="mckd2.F1">Figure 1</xref> for a diagnostic algorithm for inherited kidney disease.</p>
        <p><bold>Hereditary glomerulonephritis.</bold> Affected individuals usually have proteinuria and/or hematuria. If blood or protein is present in the urine, consider inherited glomerulonephritis (e.g., <related-object link-type="booklink" source-id="gene" document-id="alport" document-type="chapter">Alport syndrome</related-object>). Rarely, individuals with <italic toggle="yes">UMOD-</italic>associated kidney disease have been found to have proteinuria; however, this is uncharacteristic.</p>
        <p><bold>Polycystic kidney disease.</bold> If the urinary sediment is bland (i.e., with little blood or protein) in persons with kidney disease inherited in an autosomal dominant manner, one must exclude <related-object link-type="booklink" source-id="gene" document-id="pkd-ad" document-type="chapter">autosomal dominant polycystic kidney disease</related-object> (ADPKD), in which a large number of cysts are seen on renal ultrasound examination in affected individuals older than age 25 years.</p>
        <p><bold>Other forms of ADTKD.</bold> If the individual does not have ADPKD and the urinary sediment is bland, consider the following forms of autosomal dominant tubulointerstitial kidney disease:</p>
        <list list-type="bullet">
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="mckd1" document-type="chapter">ADTKD-<italic toggle="yes">MUC1</italic></related-object> is associated with pathogenic variants in <italic toggle="yes">MUC1</italic>. Affected individuals have slowly progressive chronic kidney disease and minimal proteinuria. An important differentiating factor is that in ADTKD-<italic toggle="yes">MUC1</italic> gout usually only occurs in the setting of Stage III or later chronic kidney disease. Affected individuals do not suffer from anemia or other manifestations in childhood.</p>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="hyper-nfj2" document-type="chapter">ADTKD-<italic toggle="yes">REN</italic></related-object> is associated with pathogenic variants in <italic toggle="yes">REN</italic> [<xref ref-type="bibr" rid="mckd2.REF.zivn_.2009.204">Zivn&#x000e1; et al 2009</xref>]. Like ADTKD-<italic toggle="yes">UMOD</italic>, this condition is associated with early-onset gout and slowly progressive chronic kidney disease. Persons with a <italic toggle="yes">REN</italic> pathogenic variant also manifest hypoproliferative anemia in childhood.</p>
          </list-item>
        </list>
        <p><related-object link-type="booklink" source-id="gene" document-id="fabry" document-type="chapter"><bold>Fabry disease</bold></related-object><bold>,</bold> an X-linked disorder, results from deficient activity of the enzyme &#x003b1;-galactosidase (&#x003b1;-Gal) A and progressive lysosomal deposition of globotriaosylceramide (GL-3) in cells throughout the body. The classic form, occurring in males with &#x0003c;1% &#x003b1;-Gal A activity, usually has its onset in childhood or adolescence with periodic crises of severe pain in the extremities (acroparesthesias), the appearance of vascular cutaneous lesions (angiokeratomas), hypohidrosis, characteristic corneal and lenticular opacities, and proteinuria (which usually exceeds that seen in ADTKD-<italic toggle="yes">UMOD</italic>). Gradual deterioration of renal function to ESRD usually occurs in the third to fifth decade. Males with &#x0003e;1% &#x003b1;-Gal A activity have a cardiac or renal variant phenotype. Rarely, heterozygous carrier females may have symptoms as severe as those observed in males with the classic phenotype.</p>
      </sec>
      <sec id="mckd2.Management">
        <title>Management</title>
        <sec id="mckd2.Evaluations_Following_Initial_Diag">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs in an individual diagnosed with ADTKD-<italic toggle="yes">UMOD</italic>, the following evaluations are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Determination of kidney function (measurement of serum creatinine concentration)</p>
            </list-item>
            <list-item>
              <p>Measurement of serum uric acid concentration</p>
            </list-item>
            <list-item>
              <p>Referral to a nephrologist because of the possibility of progression to chronic kidney disease</p>
            </list-item>
            <list-item>
              <p>Consultation with a clinical geneticist and/or genetic counselor</p>
            </list-item>
          </list>
        </sec>
        <sec id="mckd2.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>
            <bold>Hyperuricemia/gout</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Acute gout typically responds well to prednisone, short-term nonsteroidal anti-inflammatory drugs (NSAIDs), or colchicine.</p>
            </list-item>
            <list-item>
              <p>Gout prevention with allopurinol or probenecid should be considered.</p>
              <list list-type="bullet">
                <list-item>
                  <p>With allopurinol treatment, serum uric acid concentration returns to normal and gout attacks can be entirely prevented.</p>
                </list-item>
                <list-item>
                  <p>Lifelong therapy with allopurinol may be required.</p>
                </list-item>
                <list-item>
                  <p>In individuals with allergies or intolerance to allopurinol, febuxostat may be considered; however, no data on the use of this medication in <italic toggle="yes">UMOD</italic>-associated kidney disease are available at present.</p>
                </list-item>
              </list>
            </list-item>
          </list>
          <p><bold>Kidney disease.</bold> Referral to a nephrologist is indicated to monitor kidney function, evaluate for manifestations of chronic kidney disease, and prepare for renal replacement therapy when renal insufficiency occurs.</p>
          <list list-type="bullet">
            <list-item>
              <p>Renal replacement therapies such as hemodialysis and peritoneal dialysis replace renal function but are associated with potential complications.</p>
            </list-item>
            <list-item>
              <p>Kidney transplantation cures ADTKD-<italic toggle="yes">UMOD</italic>. The transplanted kidney does not develop the disease.</p>
            </list-item>
            <list-item>
              <p>Allopurinol may slow the progression of kidney disease, although reliable data are not available [<xref ref-type="bibr" rid="mckd2.REF.pirson.2000.357">Pirson et al 2000</xref>, <xref ref-type="bibr" rid="mckd2.REF.fairbanks.2002.597">Fairbanks et al 2002</xref>].</p>
            </list-item>
          </list>
        </sec>
        <sec id="mckd2.Prevention_of_Primary_Manifestatio">
          <title>Prevention of Primary Manifestations</title>
          <p>Treatment of hyperuricemia with allopurinol, probenecid, or febuxostat can prevent development of gout.</p>
          <p>Kidney transplantation cures ADTKD-<italic toggle="yes">UMOD</italic>. The transplanted kidney does not develop the disease.</p>
        </sec>
        <sec id="mckd2.Surveillance">
          <title>Surveillance</title>
          <p>Appropriate surveillance includes the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>Measurement of serum creatinine concentration at least annually in affected individuals, and more frequently in those with severe disease</p>
            </list-item>
            <list-item>
              <p>Measurement of serum uric acid concentration at least annually</p>
            </list-item>
          </list>
        </sec>
        <sec id="mckd2.AgentsCircumstances_to_Avoid">
          <title>Agents/Circumstances to Avoid</title>
          <p>Volume depletion and dehydration may worsen hyperuricemia and lead to more frequent attacks of gout.</p>
          <p>High meat and seafood intake could exacerbate gout.</p>
          <p>Drugs known to be nephrotoxic should be avoided. NSAIDs are appropriate for short-term administration for treatment of gout or similar painful conditions. However, patients should avoid chronic daily use.</p>
        </sec>
        <sec id="mckd2.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>It is appropriate to evaluate apparently asymptomatic relatives of an affected individual by molecular genetic testing for the familial <italic toggle="yes">UMOD</italic> pathogenic variant in order to identify as early as possible those who would benefit from initiation of treatment and preventive measures. Particularly important are:</p>
          <list list-type="bullet">
            <list-item>
              <p>Adolescents because of their increased risk for gout, which can be prevented with allopurinol treatment;</p>
            </list-item>
            <list-item>
              <p>Relatives interested in donating a kidney to an affected family member.</p>
            </list-item>
          </list>
          <p>See <xref ref-type="sec" rid="mckd2.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="mckd2.Pregnancy_Management">
          <title>Pregnancy Management</title>
          <p>No pregnancy issues are particular to ADTKD-<italic toggle="yes">UMOD</italic>. However, in general, chronic kidney disease, depending on the stage, can affect pregnancy through increased hypertension and increased fetal loss.</p>
          <p>Women of childbearing age who are taking medications such as allopurinol or an angiotensin-converting enzyme (ACE) inhibitor should discuss their medication regimen with their physician prior to conception.</p>
          <list list-type="bullet">
            <list-item>
              <p>A recent study has suggested that allopurinol use during pregnancy may be associated with fetal malformations. While the study included women who were on many other medications when they became pregnant, allopurinol should be discontinued in women who are pregnant or who may become pregnant [<xref ref-type="bibr" rid="mckd2.REF.hoeltzenbein.2013.e66637">Hoeltzenbein et al 2013</xref>].</p>
            </list-item>
            <list-item>
              <p>Similarly, the use of ACE inhibitors during the second and third trimesters of pregnancy can result in fetal damage and death. Women who are taking ACE inhibitors prior to pregnancy or at the time of conception should be transitioned to another antihypertensive medication.</p>
            </list-item>
          </list>
          <p>Ideally, women should not be taking either allopurinol or an ACE inhibitor during pregnancy.</p>
        </sec>
        <sec id="mckd2.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p>
        </sec>
      </sec>
      <sec id="mckd2.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="mckd2.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>Autosomal dominant tubulointerstitial kidney disease, <italic toggle="yes">UMOD</italic>-related (ADTKD-<italic toggle="yes">UMOD</italic>) is inherited in an autosomal dominant manner.</p>
        </sec>
        <sec id="mckd2.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Most individuals diagnosed with ADTKD-<italic toggle="yes">UMOD</italic> have an affected parent.</p>
            </list-item>
            <list-item>
              <p>A proband with ADTKD-<italic toggle="yes">UMOD</italic> may have the disorder as the result of a <italic toggle="yes">de novo UMOD</italic> pathogenic variant.</p>
            </list-item>
            <list-item>
              <p>Recommendations for the evaluation of parents of a proband with an apparent <italic toggle="yes">de novo</italic> pathogenic variant include <italic toggle="yes">UMOD</italic> molecular genetic testing and measurement of serum concentrations of uric acid and creatinine.</p>
            </list-item>
            <list-item>
              <p>If the pathogenic variant found in the proband cannot be detected in leukocyte DNA of either parent, possible explanations include a <italic toggle="yes">de novo</italic> pathogenic variant in the proband or germline mosaicism in a parent. (Although no instances of germline mosaicism have been reported, it remains a possibility.)</p>
            </list-item>
            <list-item>
              <p>An apparently negative family history cannot be confirmed without molecular genetic testing for the familial <italic toggle="yes">UMOD</italic> pathogenic variant. Evaluation of parents may determine that one is affected but has escaped previous diagnosis because of failure by health care professionals to recognize the syndrome, a milder phenotypic presentation, early death of the parent before the onset of symptoms, and/or late onset of the disease in the affected parent.</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The risk to the sibs of the proband depends on the genetic status of the proband's parents: if a parent of the proband is affected and/or has a <italic toggle="yes">UMOD</italic> pathogenic variant, the risk to the sibs of inheriting the variant is 50%.</p>
            </list-item>
            <list-item>
              <p>When the parents are clinically unaffected, the risk to the sibs of a proband appears to be low.</p>
            </list-item>
            <list-item>
              <p>Parental germline mosaicism has not been reported.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> Each child of an individual with ADTKD-<italic toggle="yes">UMOD</italic> has a 50% chance of inheriting the pathogenic variant.</p>
          <p><bold>Other family members.</bold> The risk to other family members depends on the status of the proband's parents: if a parent has the <italic toggle="yes">UMOD</italic> pathogenic variant, his or her family members may be at risk.</p>
        </sec>
        <sec id="mckd2.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p>See Management, <xref ref-type="sec" rid="mckd2.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</xref> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p>
          <p><bold>Considerations in families with an apparent <italic toggle="yes">de novo</italic> pathogenic variant.</bold> When neither parent of a proband with an autosomal dominant condition has the pathogenic variant or clinical evidence of the disorder, it is likely that the pathogenic variant is <italic toggle="yes">de novo</italic>. However, non-medical explanations including alternate paternity or maternity (e.g., with assisted reproduction) and undisclosed adoption could also be explored.</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected or at risk.</p>
            </list-item>
          </list>
          <p><bold>Molecular genetic testing of at-risk asymptomatic relatives</bold> of individuals with ADTKD-<italic toggle="yes">UMOD</italic> is possible after molecular genetic testing has identified the specific pathogenic variant in the family. Such testing is helpful in predicting the future development of chronic kidney disease and should be performed if the family member is considering becoming a kidney donor.</p>
          <p><bold>Testing of at-risk asymptomatic individuals younger than age 18 years.</bold> Because of the increased risk for gout, which can be prevented with allopurinol treatment in adolescents who have a <italic toggle="yes">UMOD</italic> pathogenic variant, testing of at-risk family members during adolescence may be appropriate.</p>
          <p><bold>Symptomatic individuals younger than age 18 years</bold> usually benefit from having a specific diagnosis established.</p>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="mckd2.Prenatal_Testing_and_Preimplantati">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p>Once the <italic toggle="yes">UMOD</italic> pathogenic variant has been identified in an affected family member, prenatal testing for a pregnancy at increased risk and preimplantation genetic diagnosis for ADTKD-<italic toggle="yes">UMOD</italic> are possible.</p>
          <p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. Although most centers would consider decisions about prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p>
          <p>Individuals who have ADTKD-<italic toggle="yes">UMOD</italic> will not be affected with kidney disease for 30 to 40 years. It is anticipated that rapid advances in treatment, renal replacement therapy, and transplantation will result in marked improvements in care for individuals with this disease.</p>
        </sec>
      </sec>
      <sec id="mckd2.Resources">
        <title>Resources</title>
      </sec>
      <sec id="mckd2.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <sec id="mckd2.Molecular_Genetic_Pathogenesis">
          <title>Molecular Genetic Pathogenesis</title>
          <p>Autosomal dominant tubulointerstitial kidney disease, <italic toggle="yes">UMOD</italic>-related (ADTKD-<italic toggle="yes">UMOD</italic>) is an endoplasmic reticulum storage disease resulting in chronic renal failure from deposition of abnormal uromodulin over time [<xref ref-type="bibr" rid="mckd2.REF.rampoldi.2003.3369">Rampoldi et al 2003</xref>, <xref ref-type="bibr" rid="mckd2.REF.bleyer.2004.974">Bleyer et al 2004</xref>].</p>
          <p><bold>Gene structure.</bold> The gene comprises 11 exons. Exon 1 is non-coding. Note: Exon numbering may vary in the literature; this <italic toggle="yes">GeneReview</italic> uses that of <xref ref-type="bibr" rid="mckd2.REF.williams.2009.2963">Williams et al [2009]</xref>. See <related-object source-id="gene" document-id="mckd2" object-id="mckd2.molgen.TA">Table A</related-object> for a detailed summary of gene and protein information.</p>
          <p><bold>Pathogenic variants.</bold> More than 40 pathogenic variants have been found in families with ADTKD-<italic toggle="yes">UMOD</italic> [<xref ref-type="bibr" rid="mckd2.REF.hart.2002.882">Hart et al 2002</xref>, <xref ref-type="bibr" rid="mckd2.REF.dahan.2003.2883">Dahan et al 2003</xref>, <xref ref-type="bibr" rid="mckd2.REF.rampoldi.2003.3369">Rampoldi et al 2003</xref>, <xref ref-type="bibr" rid="mckd2.REF.turner.2003.1398">Turner et al 2003</xref>, <xref ref-type="bibr" rid="mckd2.REF.wolf.2003.1580">Wolf et al 2003</xref>, <xref ref-type="bibr" rid="mckd2.REF.kudo.2004.1589">Kudo et al 2004</xref>, <xref ref-type="bibr" rid="mckd2.REF.lens.2005.52">Lens et al 2005</xref>, <xref ref-type="bibr" rid="mckd2.REF.puig.2006.1295">Puig et al 2006</xref>]. Pathogenic variants are almost exclusively missense variants.</p>
          <p>The majority of the pathogenic variants causing ADTKD-<italic toggle="yes">UMOD</italic> involve an addition or deletion of a cysteine residue or highly conserved polar residue that is likely to alter either disulfide bond formation, thereby disrupting the correct protein folding [<xref ref-type="bibr" rid="mckd2.REF.whiteman.2003.727">Whiteman &#x00026; Handford 2003</xref>], or hydrophobicity distribution responsible for protein spatial flexibility [<xref ref-type="bibr" rid="mckd2.REF.xu.1997.68">Xu et al 1997</xref>].</p>
          <p>Pathogenic variants have been identified in exons 3, 4, 5, and 7 of <italic toggle="yes">UMOD</italic>.</p>
          <table-wrap id="mckd2.T.umod_pathogenic_variants_discuss" orientation="portrait" position="anchor">
            <label>Table 4. </label>
            <caption>
              <p><italic toggle="yes">UMOD</italic> Pathogenic Variants Discussed in This <italic toggle="yes">GeneReview</italic></p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_mckd2.T.umod_pathogenic_variants_discuss_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                  <th id="hd_h_mckd2.T.umod_pathogenic_variants_discuss_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                  <th id="hd_h_mckd2.T.umod_pathogenic_variants_discuss_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_mckd2.T.umod_pathogenic_variants_discuss_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.278_289delTCTGCCCCGAAGinsCCGCCTCCT</td>
                  <td headers="hd_h_mckd2.T.umod_pathogenic_variants_discuss_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Val93_Gly97delinsAlaAlaSerCys</td>
                  <td headers="hd_h_mckd2.T.umod_pathogenic_variants_discuss_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                    <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_003361.3">NM_003361.3</ext-link>
                    <break/>
                    <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_003352.2">NP_003352.2</ext-link>
                  </td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn>
                <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
              </fn>
              <fn>
                <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p><bold>Normal gene product.</bold> Uromodulin is a large glycoprotein with a large number of cysteine residues [<xref ref-type="bibr" rid="mckd2.REF.serafinicessi.2003.658">Serafini-Cessi et al 2003</xref>] (reference sequence <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_001008390.1">NP_001008390.1</ext-link>). Uromodulin is produced only in the thick ascending limb of Henle's loop of the renal tubule; therefore, disease is limited to the kidney. While uromodulin is the most common protein found in normal human urine, its function is uncertain. Uromodulin is likely responsible for maintaining the integrity of the thick ascending limb of Henle's loop, the kidney region in which the water permeability is remarkably low and salts are efficiently absorbed. Although it has been postulated that uromodulin is important in preventing urinary tract infections, individuals with abnormal uromodulin do not have an increased incidence of urinary tract infections or kidney stones.</p>
          <p><bold>Abnormal gene product.</bold> Increasing evidence suggests that intracellular accumulation of abnormal uromodulin leads to increased apoptosis and is likely an important contributor to the pathogenesis of this disorder [<xref ref-type="bibr" rid="mckd2.REF.williams.2009.2963">Williams et al 2009</xref>]. Abnormal uromodulin may also prevent the proper function of ion channels in the thick ascending limb, resulting in mild natriuresis leading to proximal tubular reabsorption of urate and hyperuricemia [<xref ref-type="bibr" rid="mckd2.REF.renigunta.2011.2224">Renigunta et al 2011</xref>].</p>
          <p>Histochemical studies have shown abnormal uromodulin deposition in the endoplasmic reticulum of cells of the thick ascending limb of Henle's loop. In heterozygotes, urinary excretion of uromodulin is much less than half the expected amount, likely resulting from a dominant-negative effect (e.g., interference with synthesis of the normal uromodulin by abnormal uromodulin). Accordingly, the abnormal expression of the mutated uromodulin in the thick ascending limb of Henle's loop of the renal tubule decreases NaCl reabsorption and subsequently induces a state of volume contraction known to promote the proximal reabsorption of urate [<xref ref-type="bibr" rid="mckd2.REF.renigunta.2011.2224">Renigunta et al 2011</xref>].</p>
        </sec>
      </sec>
      <sec id="mckd2.References">
        <title>References</title>
        <sec id="mckd2.Published_GuidelinesConsensus_Stat">
          <title>Published Guidelines/Consensus Statements</title>
          <ref-list id="mckd2.Published_GuidelinesConsensus_Stat.reflist0">
            <ref id="mckd2.REF1">
              <mixed-citation publication-type="web">Committee on Bioethics, Committee on Genetics, and American College of Medical Genetics and Genomics Social, Ethical, Legal Issues Committee. Ethical and policy issues in genetic testing and screening of children. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pediatrics.aappublications.org/content/131/3/620.full.pdf">online</ext-link>. 2013. Accessed 2-14-17.</mixed-citation>
            </ref>
            <ref id="mckd2.REF2">
              <mixed-citation publication-type="web">National Society of Genetic Counselors. Position statement on genetic testing of minors for adult-onset disorders. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://nsgc.org/p/bl/et/blogid=47&#x00026;blogaid=28">online</ext-link>. 2012. Accessed 2-14-17.</mixed-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="mckd2.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="mckd2.Literature_Cited.reflist0">
            <ref id="mckd2.REF.bleyer.2010.366">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bleyer</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hart</surname>
                    <given-names>PS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kmoch</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>Hereditary interstitial kidney disease.</article-title>
                <source>Semin Nephrol.</source>
                <year>2010</year>
                <volume>30</volume>
                <fpage>366</fpage>
                <lpage>73</lpage>
                <pub-id pub-id-type="pmid">20807609</pub-id>
              </element-citation>
            </ref>
            <ref id="mckd2.REF.bleyer.2003.867">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bleyer</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hart</surname>
                    <given-names>TC</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Familial juvenile hyperuricaemic nephropathy.</article-title>
                <source>QJM</source>
                <volume>96</volume>
                <fpage>867</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">14566042</pub-id>
              </element-citation>
            </ref>
            <ref id="mckd2.REF.bleyer.2004.974">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bleyer</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hart</surname>
                    <given-names>TC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shihabi</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robins</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoyer</surname>
                    <given-names>JR</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Mutations in the uromodulin gene decrease urinary excretion of Tamm-Horsfall protein.</article-title>
                <source>Kidney Int</source>
                <volume>66</volume>
                <fpage>974</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">15327389</pub-id>
              </element-citation>
            </ref>
            <ref id="mckd2.REF.bleyer.2005.824">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bleyer</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hart</surname>
                    <given-names>TC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Willingham</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iskandar</surname>
                    <given-names>SS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gorry</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trachtman</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Clinico-pathologic findings in medullary cystic kidney disease type 2.</article-title>
                <source>Pediatr Nephrol</source>
                <volume>20</volume>
                <fpage>824</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">15844001</pub-id>
              </element-citation>
            </ref>
            <ref id="mckd2.REF.bleyer.2003.36">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bleyer</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Woodard</surname>
                    <given-names>AS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shihabi</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sandhu</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhu</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Satko</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weller</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Deterding</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McBride</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gorry</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xu</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ganier</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hart</surname>
                    <given-names>TC</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Clinical characterization of a family with a mutation in the uromodulin (Tamm-Horsfall glycoprotein) gene.</article-title>
                <source>Kidney Int</source>
                <volume>64</volume>
                <fpage>36</fpage>
                <lpage>42</lpage>
                <pub-id pub-id-type="pmid">12787393</pub-id>
              </element-citation>
            </ref>
            <ref id="mckd2.REF.cameron.1993.105">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cameron</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moro</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Simmonds</surname>
                    <given-names>HA</given-names>
                  </name>
                </person-group>
                <year>1993</year>
                <article-title>Gout, uric acid and purine metabolism in paediatric nephrology.</article-title>
                <source>Pediatr Nephrol</source>
                <volume>7</volume>
                <fpage>105</fpage>
                <lpage>18</lpage>
                <pub-id pub-id-type="pmid">8439471</pub-id>
              </element-citation>
            </ref>
            <ref id="mckd2.REF.dahan.2003.2883">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dahan</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Devuyst</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smaers</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vertommen</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Loute</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poux</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Viron</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jacquot</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gagnadoux</surname>
                    <given-names>MF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chauveau</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buchler</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cochat</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cosyns</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mougenot</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rider</surname>
                    <given-names>MH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Antignac</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Verellen-Dumoulin</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pirson</surname>
                    <given-names>Y</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>A cluster of mutations in the UMOD gene causes familial juvenile hyperuricemic nephropathy with abnormal expression of uromodulin.</article-title>
                <source>J Am Soc Nephrol</source>
                <volume>14</volume>
                <fpage>2883</fpage>
                <lpage>93</lpage>
                <pub-id pub-id-type="pmid">14569098</pub-id>
              </element-citation>
            </ref>
            <ref id="mckd2.REF.dahan.2001.2348">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dahan</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fuchshuber</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Adamis</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smaers</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kroiss</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Loute</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cosyns</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hildebrandt</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Verellen-Dumoulin</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pirson</surname>
                    <given-names>Y</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Familial juvenile hyperuricemic nephropathy and autosomal dominant medullary cystic kidney disease type 2: two facets of the same disease?</article-title>
                <source>J Am Soc Nephrol</source>
                <volume>12</volume>
                <fpage>2348</fpage>
                <lpage>57</lpage>
                <pub-id pub-id-type="pmid">11675411</pub-id>
              </element-citation>
            </ref>
            <ref id="mckd2.REF.eckardt.2015.676">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Eckardt</surname>
                    <given-names>K-U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alper</surname>
                    <given-names>SL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Antignac</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bleyer</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chauveau</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dahan</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Deltas</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hosking</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kmoch</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rampoldi</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wiesener</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wolf</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Devuyst</surname>
                    <given-names>O</given-names>
                  </name>
                </person-group>
                <article-title>Autosomal dominant tubulointerstitial kidney disease: Diagnosis, classification, and management- a KDIGO consensus report.</article-title>
                <source>Kidney Int</source>
                <year>2015</year>
                <volume>88</volume>
                <fpage>676</fpage>
                <lpage>683</lpage>
                <pub-id pub-id-type="pmid">25738250</pub-id>
              </element-citation>
            </ref>
            <ref id="mckd2.REF.fairbanks.2002.597">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fairbanks</surname>
                    <given-names>LD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cameron</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Venkat-Raman</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rigden</surname>
                    <given-names>SP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rees</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <article-title>Van'T Hoff W, Mansell M, Pattison J, Goldsmith DJ, Simmonds HA. Early treatment with allopurinol in familial juvenile hyerpuricaemic nephropathy (FJHN) ameliorates the long-term progression of renal disease.</article-title>
                <source>QJM</source>
                <year>2002</year>
                <volume>95</volume>
                <fpage>597</fpage>
                <lpage>607</lpage>
                <pub-id pub-id-type="pmid">12205338</pub-id>
              </element-citation>
            </ref>
            <ref id="mckd2.REF.gagnadoux.1989.50">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gagnadoux</surname>
                    <given-names>MF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bacri</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Broyer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Habib</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>1989</year>
                <article-title>Infantile chronic tubulo-interstitial nephritis with cortical microcysts: variant of nephronophthisis or new disease entity?</article-title>
                <source>Pediatr Nephrol</source>
                <volume>3</volume>
                <fpage>50</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">2702088</pub-id>
              </element-citation>
            </ref>
            <ref id="mckd2.REF.gambaro.2006.663">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gambaro</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Feltrin</surname>
                    <given-names>GP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lupo</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonfante</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D'Angelo</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Antonello</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Medullary sponge kidney (Lenarduzzi-Cacchi-Ricci disease): a Padua Medical School discovery in the 1930s.</article-title>
                <source>Kidney Int</source>
                <volume>69</volume>
                <fpage>663</fpage>
                <lpage>70</lpage>
                <pub-id pub-id-type="pmid">16395272</pub-id>
              </element-citation>
            </ref>
            <ref id="mckd2.REF.harkness.1969.773">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Harkness</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nicol</surname>
                    <given-names>AD</given-names>
                  </name>
                </person-group>
                <year>1969</year>
                <article-title>Plasma uric acid levels in children.</article-title>
                <source>Arch Dis Child</source>
                <volume>44</volume>
                <fpage>773</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">5356987</pub-id>
              </element-citation>
            </ref>
            <ref id="mckd2.REF.hart.2002.882">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hart</surname>
                    <given-names>TC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gorry</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hart</surname>
                    <given-names>PS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Woodard</surname>
                    <given-names>AS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shihabi</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sandhu</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shirts</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xu</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhu</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barmada</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bleyer</surname>
                    <given-names>AJ</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Mutations of the UMOD gene are responsible for medullary cystic kidney disease 2 and familial juvenile hyperuricaemic nephropathy.</article-title>
                <source>J Med Genet</source>
                <volume>39</volume>
                <fpage>882</fpage>
                <lpage>92</lpage>
                <pub-id pub-id-type="pmid">12471200</pub-id>
              </element-citation>
            </ref>
            <ref id="mckd2.REF.hildebrandt.1992.802">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hildebrandt</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Waldherr</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kutt</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brandis</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>1992</year>
                <article-title>The nephronophthisis complex: clinical and genetic aspects.</article-title>
                <source>Clin Investig</source>
                <volume>70</volume>
                <fpage>802</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">1450635</pub-id>
              </element-citation>
            </ref>
            <ref id="mckd2.REF.hoeltzenbein.2013.e66637">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hoeltzenbein</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stieler</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Panse</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wacker</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schaefer</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <article-title>Allopurinol use during pregnancy: Outcome of 31 prospectively ascertained cases and a phenotype possibly indicative for teratogenicity.</article-title>
                <source>PLoS One.</source>
                <year>2013</year>
                <volume>8</volume>
                <fpage>e66637</fpage>
                <pub-id pub-id-type="pmid">23840514</pub-id>
              </element-citation>
            </ref>
            <ref id="mckd2.REF.kirby.2013.299">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kirby</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gnirke</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jaffe</surname>
                    <given-names>DB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bare&#x00161;ov&#x000e1;</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pochet</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blumenstiel</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ye</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aird</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stevens</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robinson</surname>
                    <given-names>JT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cabili</surname>
                    <given-names>MN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gat-Viks</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kelliher</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Daza</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DeFelice</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>H&#x0016f;lkov&#x000e1;</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sovov&#x000e1;</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vylet'al</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Antignac</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guttman</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Handsaker</surname>
                    <given-names>RE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Perrin</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steelman</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sigurdsson</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheinman</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sougnez</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cibulskis</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parkin</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Green</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rossin</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zody</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xavier</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pollak</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alper</surname>
                    <given-names>SL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lindblad-Toh</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gabriel</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hart</surname>
                    <given-names>PS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Regev</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nusbaum</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kmoch</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bleyer</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lander</surname>
                    <given-names>ES</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Daly</surname>
                    <given-names>MJ</given-names>
                  </name>
                </person-group>
                <article-title>Mutations causing medullary cystic kidney disease type 1 lie in a large VNTR in MUC1 missed by massively parallel sequencing.</article-title>
                <source>Nat Genet.</source>
                <year>2013</year>
                <volume>45</volume>
                <fpage>299</fpage>
                <lpage>303</lpage>
                <pub-id pub-id-type="pmid">23396133</pub-id>
              </element-citation>
            </ref>
            <ref id="mckd2.REF.kudo.2004.1589">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kudo</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kamatani</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tezuka</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taniguchi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamanaka</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yabe</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Osabe</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shinohara</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nomura</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Segawa</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miyamoto</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moritani</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kunika</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Itakura</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Familial juvenile hyperuricemic nephropathy: detection of mutations in the uromodulin gene in five Japanese families.</article-title>
                <source>Kidney Int</source>
                <volume>65</volume>
                <fpage>1589</fpage>
                <lpage>97</lpage>
                <pub-id pub-id-type="pmid">15086896</pub-id>
              </element-citation>
            </ref>
            <ref id="mckd2.REF.lens.2005.52">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lens</surname>
                    <given-names>XM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Banet</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Outeda</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barrio-Lucia</surname>
                    <given-names>V</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>A novel pattern of mutation in uromodulin disorders: autosomal dominant medullary cystic kidney disease type 2, familial juvenile hyperuricemic nephropathy, and autosomal dominant glomerulocystic kidney disease.</article-title>
                <source>Am J Kidney Dis</source>
                <volume>46</volume>
                <fpage>52</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">15983957</pub-id>
              </element-citation>
            </ref>
            <ref id="mckd2.REF.mcbride.1998.357">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>McBride</surname>
                    <given-names>MB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rigden</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haycock</surname>
                    <given-names>GB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dalton</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van't Hoff</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rees</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raman</surname>
                    <given-names>GV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moro</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ogg</surname>
                    <given-names>CS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cameron</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Simmonds</surname>
                    <given-names>HA</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Presymptomatic detection of familial juvenile hyperuricaemic nephropathy in children.</article-title>
                <source>Pediatr Nephrol</source>
                <volume>12</volume>
                <fpage>357</fpage>
                <lpage>64</lpage>
                <pub-id pub-id-type="pmid">9686952</pub-id>
              </element-citation>
            </ref>
            <ref id="mckd2.REF.mikkelsen.1965.242">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mikkelsen</surname>
                    <given-names>WM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dodge</surname>
                    <given-names>HJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Valkenburg</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>1965</year>
                <article-title>the distribution of serum uric acid values in a population unselected as to gout or hyperuricemia: Tecumseh, Michigan 1959-1960.</article-title>
                <source>Am J Med.</source>
                <volume>39</volume>
                <fpage>242</fpage>
                <lpage>51</lpage>
                <pub-id pub-id-type="pmid">14320691</pub-id>
              </element-citation>
            </ref>
            <ref id="mckd2.REF.moro.1991.263">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Moro</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ogg</surname>
                    <given-names>CS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Simmonds</surname>
                    <given-names>HA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cameron</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chantler</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McBride</surname>
                    <given-names>MB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Duley</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davies</surname>
                    <given-names>PM</given-names>
                  </name>
                </person-group>
                <year>1991</year>
                <article-title>Familial juvenile gouty nephropathy with renal urate hypoexcretion preceding renal disease.</article-title>
                <source>Clin Nephrol</source>
                <volume>35</volume>
                <fpage>263</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">1873940</pub-id>
              </element-citation>
            </ref>
            <ref id="mckd2.REF.pirson.2000.357">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pirson</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Loute</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cosyns</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dahan</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Verellen</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Autosomal-dominant chronic interstitial nephritis with early hyperuricemia.</article-title>
                <source>Adv Nephrol Necker Hosp</source>
                <volume>30</volume>
                <fpage>357</fpage>
                <lpage>69</lpage>
                <pub-id pub-id-type="pmid">11068651</pub-id>
              </element-citation>
            </ref>
            <ref id="mckd2.REF.puig.1993.357">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Puig</surname>
                    <given-names>JG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miranda</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mateos</surname>
                    <given-names>FA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Picazo</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jimenez</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Calvin</surname>
                    <given-names>TS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gil</surname>
                    <given-names>AA</given-names>
                  </name>
                </person-group>
                <year>1993</year>
                <article-title>Hereditary nephropathy associated with hyperuricemia and gout.</article-title>
                <source>Arch Intern Med</source>
                <volume>153</volume>
                <fpage>357</fpage>
                <lpage>65</lpage>
                <pub-id pub-id-type="pmid">8427538</pub-id>
              </element-citation>
            </ref>
            <ref id="mckd2.REF.puig.2006.1295">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Puig</surname>
                    <given-names>JG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Prior</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martinez-Ara</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Torres</surname>
                    <given-names>RJ</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Familial nephropathy associated with hyperuricemia in spain: our experience with 3 families harbouring a UMOD mutation.</article-title>
                <source>Nucleosides Nucleotides Nucleic Acids</source>
                <volume>25</volume>
                <fpage>1295</fpage>
                <lpage>300</lpage>
                <pub-id pub-id-type="pmid">17065110</pub-id>
              </element-citation>
            </ref>
            <ref id="mckd2.REF.rampoldi.2003.3369">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rampoldi</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Caridi</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Santon</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boaretto</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bernascone</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lamorte</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tardanico</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dagnino</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Colussi</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scolari</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ghiggeri</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amoroso</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Casari</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Allelism of MCKD, FJHN and GCKD caused by impairment of uromodulin export dynamics.</article-title>
                <source>Hum Mol Genet</source>
                <volume>12</volume>
                <fpage>3369</fpage>
                <lpage>84</lpage>
                <pub-id pub-id-type="pmid">14570709</pub-id>
              </element-citation>
            </ref>
            <ref id="mckd2.REF.renigunta.2011.2224">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Renigunta</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Renigunta</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saritas</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Decher</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mutig</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Waldegger</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Tamm-Horsfall glycoprotein interacts with renal outer medullary potassium channel ROMK2 and regulates its function.</article-title>
                <source>J Biol Chem.</source>
                <volume>286</volume>
                <fpage>2224</fpage>
                <lpage>35</lpage>
                <pub-id pub-id-type="pmid">21081491</pub-id>
              </element-citation>
            </ref>
            <ref id="mckd2.REF.richmond.1981.163">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Richmond</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kincaid-Smith</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Whitworth</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Becker</surname>
                    <given-names>GJ</given-names>
                  </name>
                </person-group>
                <year>1981</year>
                <article-title>Familial urate nephropathy.</article-title>
                <source>Clin Nephrol</source>
                <volume>16</volume>
                <fpage>163</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">7296976</pub-id>
              </element-citation>
            </ref>
            <ref id="mckd2.REF.sch_ffer.2010.1355">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sch&#x000e4;ffer</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gombos</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meichelbeck</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kiss</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hart</surname>
                    <given-names>PS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bleyer</surname>
                    <given-names>AJ</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Childhood course of renal insufficiency in a family with a uromodulin gene mutation.</article-title>
                <source>Pediatr Nephrol.</source>
                <year>2010</year>
                <volume>25</volume>
                <fpage>1355</fpage>
                <lpage>60</lpage>
                <pub-id pub-id-type="pmid">20151160</pub-id>
              </element-citation>
            </ref>
            <ref id="mckd2.REF.serafinicessi.2003.658">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Serafini-Cessi</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malagolini</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cavallone</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Tamm-Horsfall glycoprotein: biology and clinical relevance.</article-title>
                <source>Am J Kidney Dis</source>
                <volume>42</volume>
                <fpage>658</fpage>
                <lpage>76</lpage>
                <pub-id pub-id-type="pmid">14520616</pub-id>
              </element-citation>
            </ref>
            <ref id="mckd2.REF.simmonds.1980.176">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Simmonds</surname>
                    <given-names>HA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Warren</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cameron</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Potter</surname>
                    <given-names>CF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farebrother</surname>
                    <given-names>DA</given-names>
                  </name>
                </person-group>
                <year>1980</year>
                <article-title>Familial gout and renal failure in young women.</article-title>
                <source>Clin Nephrol</source>
                <volume>14</volume>
                <fpage>176</fpage>
                <lpage>82</lpage>
                <pub-id pub-id-type="pmid">7428192</pub-id>
              </element-citation>
            </ref>
            <ref id="mckd2.REF.smith.2011.2766">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>GD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robinson</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stewart</surname>
                    <given-names>AP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Edwards</surname>
                    <given-names>EL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karet</surname>
                    <given-names>HI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Norden</surname>
                    <given-names>AG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sandford</surname>
                    <given-names>RN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karet Frankl</surname>
                    <given-names>FE</given-names>
                  </name>
                </person-group>
                <article-title>Characterization of a recurrent in-frame UMOD indel mutation causing late-onset autosomal dominant end-stage renal failure.</article-title>
                <source>Clin J Am Soc Nephrol.</source>
                <year>2011</year>
                <volume>6</volume>
                <fpage>2766</fpage>
                <lpage>74</lpage>
                <pub-id pub-id-type="pmid">22034507</pub-id>
              </element-citation>
            </ref>
            <ref id="mckd2.REF.stib_rkov_.2006.1301">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Stib&#x0016f;rkov&#x000e1;</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Posp&#x000ed;silov&#x000e1;</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kmoch</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sebesta</surname>
                    <given-names>I</given-names>
                  </name>
                </person-group>
                <article-title>Analysis of excretion fraction of uric acid.</article-title>
                <source>Nucleosides Nucleotides Nucleic Acids.</source>
                <year>2006</year>
                <volume>25</volume>
                <fpage>1301</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">17065111</pub-id>
              </element-citation>
            </ref>
            <ref id="mckd2.REF.turner.2003.1398">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Turner</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stacey</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harding</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kotanko</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lhotta</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Puig</surname>
                    <given-names>JG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roberts</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Torres</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thakker</surname>
                    <given-names>RV</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>UROMODULIN mutations cause familial juvenile hyperuricemic nephropathy.</article-title>
                <source>J Clin Endocrinol Metab</source>
                <volume>88</volume>
                <fpage>1398</fpage>
                <lpage>401</lpage>
                <pub-id pub-id-type="pmid">12629136</pub-id>
              </element-citation>
            </ref>
            <ref id="mckd2.REF.whiteman.2003.727">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Whiteman</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Handford</surname>
                    <given-names>PA</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Defective secretion of recombinant fragments of fibrillin-1: implications of protein misfolding for the pathogenesis of Marfan syndrome and related disorders.</article-title>
                <source>Hum Mol Genet</source>
                <volume>12</volume>
                <fpage>727</fpage>
                <lpage>37</lpage>
                <pub-id pub-id-type="pmid">12651868</pub-id>
              </element-citation>
            </ref>
            <ref id="mckd2.REF.wilcox.1996.731">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wilcox</surname>
                    <given-names>WD</given-names>
                  </name>
                </person-group>
                <year>1996</year>
                <article-title>Abnormal serum uric acid levels in children.</article-title>
                <source>J Pediatr</source>
                <volume>128</volume>
                <fpage>731</fpage>
                <lpage>41</lpage>
                <pub-id pub-id-type="pmid">8648529</pub-id>
              </element-citation>
            </ref>
            <ref id="mckd2.REF.williams.2009.2963">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Williams</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reed</surname>
                    <given-names>AAC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Galvanovskis</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Antignac</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goodship</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karet</surname>
                    <given-names>FE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kotanko</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lhotta</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moriniere</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Williams</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wong</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rorsman</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thakker</surname>
                    <given-names>RV</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Uromodulin mutations causing familial juvenile hyperuricaemic nephropathy lead to protein maturation defects and retention in the endoplasmic reticulum.</article-title>
                <source>Hum Mol Genet</source>
                <volume>18</volume>
                <fpage>2963</fpage>
                <lpage>74</lpage>
                <pub-id pub-id-type="pmid">19465746</pub-id>
              </element-citation>
            </ref>
            <ref id="mckd2.REF.wolf.2011.181">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wolf</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hildebrandt</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Nephronophthisis.</article-title>
                <source>Pediatr Nephrol</source>
                <volume>26</volume>
                <fpage>181</fpage>
                <lpage>94</lpage>
                <pub-id pub-id-type="pmid">20652329</pub-id>
              </element-citation>
            </ref>
            <ref id="mckd2.REF.wolf.2003.1580">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wolf</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mucha</surname>
                    <given-names>BE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Attanasio</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zalewski</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karle</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neumann</surname>
                    <given-names>HP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rahman</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bader</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baldamus</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Otto</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Witzgall</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fuchshuber</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hildebrandt</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Mutations of the Uromodulin gene in MCKD type 2 patients cluster in exon 4, which encodes three EGF-like domains.</article-title>
                <source>Kidney Int</source>
                <volume>64</volume>
                <fpage>1580</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">14531790</pub-id>
              </element-citation>
            </ref>
            <ref id="mckd2.REF.xu.1997.68">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Xu</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lin</surname>
                    <given-names>SL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nussinov</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>Protein binding versus protein folding: the role of hydrophilic bridges in protein associations.</article-title>
                <source>J Mol Biol</source>
                <volume>265</volume>
                <fpage>68</fpage>
                <lpage>84</lpage>
                <pub-id pub-id-type="pmid">8995525</pub-id>
              </element-citation>
            </ref>
            <ref id="mckd2.REF.zivn_.2009.204">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zivn&#x000e1;</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>H&#x0016f;lkov&#x000e1;</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matignon</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hodanov&#x000e1;</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vylet'al</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kalb&#x000e1;cov&#x000e1;</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baresov&#x000e1;</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sikora</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blazkov&#x000e1;</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zivn&#x000fd;</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iv&#x000e1;nek</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Str&#x000e1;neck&#x000fd;</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sovov&#x000e1;</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Claes</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lerut</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fryns</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hart</surname>
                    <given-names>PS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hart</surname>
                    <given-names>TC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Adams</surname>
                    <given-names>JN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pawtowski</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clemessy</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gasc</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>G&#x000fc;bler</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Antignac</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elleder</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kapp</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grimbert</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bleyer</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kmoch</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Dominant renin gene mutations associated with early-onset hyperuricemia, anemia, and chronic kidney failure.</article-title>
                <source>Am J Hum Genet.</source>
                <volume>85</volume>
                <fpage>204</fpage>
                <lpage>13</lpage>
                <pub-id pub-id-type="pmid">19664745</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="mckd2.Suggested_Reading">
          <title>Suggested Reading</title>
          <ref-list id="mckd2.Suggested_Reading.reflist0">
            <ref id="mckd2.REF.bisceglia.2006.26">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bisceglia</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Galliani</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Senger</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stallone</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sessa</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Renal cystic diseases: a review.</article-title>
                <source>Adv Anat Pathol</source>
                <volume>13</volume>
                <fpage>26</fpage>
                <lpage>56</lpage>
                <pub-id pub-id-type="pmid">16462154</pub-id>
              </element-citation>
            </ref>
            <ref id="mckd2.REF.bleyer.2006.124">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bleyer</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hart</surname>
                    <given-names>TC</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Genetic factors associated with gout and hyperuricemia.</article-title>
                <source>Adv Chronic Kidney Dis</source>
                <volume>13</volume>
                <fpage>124</fpage>
                <lpage>30</lpage>
                <pub-id pub-id-type="pmid">16580613</pub-id>
              </element-citation>
            </ref>
            <ref id="mckd2.REF.gbadegesin.2010">
              <mixed-citation publication-type="confproc">Gbadegesin R, Lavin PJ, Homstad A, Wu G, Byrd A, Eckel JJ, Winn MP. Novel insertion-deletion mutation in uromodulin in a large kindred with familial CKD and nephrotic range proteinuria. Denver, CO: American Society of Nephrology Annual Meeting; 2010.</mixed-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="mckd2.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="mckd2.Author_Notes">
          <title>Author Notes</title>
          <p>Dr. Bleyer pursues active clinical research in the area of MCKD. He is forming a registry of individuals with <italic toggle="yes">UMOD</italic> mutations. In addition, he is most interested in identifying families with the MCKD phenotype who have a mutational analysis that is negative. Please call with any questions about MCKD (336-716-4513).</p>
          <p>Wake Forest University School of Medicine, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.wakehealth.edu/School/Department-of-Nephrology.htm">Section on Nephrology</ext-link></p>
        </sec>
        <sec id="mckd2.Author_History">
          <title>Author History</title>
          <p>Anthony J Bleyer, MD, MS (2006-present)Karn Gupta, MD; Wake Forest University School of Medicine (2006-2011)P Suzanne Hart, PhD (2011-present)Stanislav Kmoch, PhD (2016-present)</p>
        </sec>
        <sec id="mckd2.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>30 June 2016 (ha) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>12 September 2013 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>15 March 2011 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>26 September 2007 (cd) Revision: prenatal diagnosis available</p>
            </list-item>
            <list-item>
              <p>12 January 2007 (me) Review posted to live Web site</p>
            </list-item>
            <list-item>
              <p>3 August 2006 (ajb) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
      <sec sec-type="figs-and-tables">
        <title/>
        <fig position="float" id="mckd2.F1" orientation="portrait">
          <label>Figure 1. </label>
          <caption>
            <p>Testing strategy for inherited kidney disease &#x02013; 2015 update</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="mckd2-Image001" position="anchor" orientation="portrait"/>
        </fig>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
